This paper is in the following e-collection/theme issue:

Early Results in Infodemiology and Infoveillance (89) Public (e)Health, Digital Epidemiology and Public Health Informatics (850) Cyberpharmacies (56) Substance Abuse (463) Opioid and Related Substance Misuse (169) Prevention and Health Promotion (1125) Pharmacovigilance (155) Web-based and Mobile Health Interventions (3618) Harm Reduction Approaches (31)

Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56755, first published .
Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study

Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study

Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study

Authors of this article:

Ian David Aronson1, 2 Author Orcid Image ;   Mary-Andrée Ardouin-Guerrier1, 2 Author Orcid Image ;   Juan Esteban Baus1 Author Orcid Image ;   Alex S Bennett1 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Journals

  1. Latkin C, Dayton L, Davey-Rothwell M, Jones A. The Relationship Between Methadone and Buprenorphine Enrollment and Overdose Prevention and Treatment Behaviors Among a Community Sample of People Who Use Opioids in Baltimore, Maryland. International Journal of Environmental Research and Public Health 2025;22(2):213 View
  2. Troike K, McShane A. Detecting Xylazine. Clinics in Laboratory Medicine 2025 View